{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:15:48Z","timestamp":1781075748643,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.reuma.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T01:40:02Z","timestamp":1467855602000},"page":"282-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis?"],"prefix":"10.1016","volume":"13","author":[{"given":"Noemi","family":"Busquets-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ortiz-Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjos\u00e9","family":"de Agust\u00edn de Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda Le\u00f3n","family":"Hern\u00e1ndez-Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imma","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Argem\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Quispe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Marin\u00e9","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sur\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2016.05.006_bib0005","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase intuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2016.05.006_bib0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention ofreactivation of latent infection","volume":"57","author":"G\u00f3mez-Reino","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2016.05.006_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/421494","article-title":"Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor","volume":"39","author":"Mohan","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.reuma.2016.05.006_bib0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1157\/13126836","article-title":"Diagnosis and treatment of tuberculosis","volume":"44","author":"Ruiz-Manzano","year":"2008","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.reuma.2016.05.006_bib0025","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"13","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.reuma.2016.05.006_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.reuma.2009.10.006","article-title":"Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis","volume":"6","author":"Tornero Molina","year":"2010","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2016.05.006_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.reuma.2011.02.001","article-title":"Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis","volume":"7","author":"Fern\u00e1ndez Sueiro","year":"2011","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2016.05.006_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.reuma.2010.12.002","article-title":"Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis","volume":"7","author":"Juanola Roura","year":"2011","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2016.05.006_bib0045","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2016.05.006_bib0050","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/522993","article-title":"A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnosticpitfalls and paradoxical response to treatment","volume":"45","author":"Arend","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.reuma.2016.05.006_bib0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/s10165-009-0157-1","article-title":"A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid","volume":"19","author":"Hirano","year":"2009","journal-title":"Mod Rheumatol."},{"key":"10.1016\/j.reuma.2016.05.006_bib0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1183\/09031936.00125607","article-title":"Re-activation of bovine tuberculosis in a patient treated with infliximab","volume":"32","author":"Larsen","year":"2008","journal-title":"Eur Respir J."},{"key":"10.1016\/j.reuma.2016.05.006_bib0065","first-page":"616","article-title":"De novo tuberculosis during infliximab therapy in a patient with Beh\u00e7et disease","volume":"7","author":"Skvara","year":"2009","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.reuma.2016.05.006_bib0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-008-1007-9","article-title":"Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors","volume":"28","author":"Fuchs","year":"2009","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.reuma.2016.05.006_bib0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10067-008-1067-x","article-title":"Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha","volume":"28","author":"Elbek","year":"2009","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.reuma.2016.05.006_bib0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/ciu796","article-title":"Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study","volume":"60","author":"Mu\u00f1oz","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.reuma.2016.05.006_bib0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1157\/13048022","article-title":"A study of the tuberculous infection in adults","volume":"203","author":"Alcaide Meg\u00edas","year":"2003","journal-title":"Rev Clin Esp."},{"key":"10.1016\/j.reuma.2016.05.006_bib0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.arbres.2011.07.003","article-title":"A study of tuberculosis infection in workers at a university general hospital: associated factors and evolution in 20 years","volume":"47","author":"Casas","year":"2011","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.reuma.2016.05.006_bib0095","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2005.040055","article-title":"Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response?","volume":"65","author":"Joven","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2016.05.006_bib0100","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1630050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1630050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T13:56:16Z","timestamp":1536587776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X1630050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1699258X1630050X"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2016.05.006","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis?","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}